NORCALPHOS injection, solution

Norcalphos by

Drug Labeling and Warnings

Norcalphos by is a Animal medication manufactured, distributed, or labeled by Nova-Tech, Inc., Zhejiang Ruibang Laboratories. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

VETERINARY INDICATIONS

Parenteral Solution

FOR ANIMAL USE ONLY

Contraindications

Do not administer intraperitoneally to horses.

Indications

For intravenous use in milk fever, and in calcium, phosphorus, magnesium and glucose deficiency in animals.

Note

Intravenous administration is always preferable. If used subcutaneously, always distribute dose in several places and massage to facilitate absorption.

Dosage & Administration

Cattle - 500 mL.

For milk fever prophylaxis, give 200-500 mL at time of calving.

Horses - 250-500 mL

Sheep - 50-125 mL

Repeat in 2 to 6 hours if needed.

This product contains no preservative. Unused portion remaining in bottle must be discarded.

Caution

Large doses administered intravenously may have toxic action on heart if the blood level of calcium is raised excessively. Doses should be carefully regulated according to severitity of hypocalcemia and injected slowly so that administration may be stopped if toxic action becomes evident.

WARNINGS AND PRECAUTIONS

KEEP OUT OF REACH OF CHILDREN

CAUTION:

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

CONTAINS

Calcium borogluconate, dextrose, magnesium borogluconate, calcium hypophosphite and base.

Total calcium chemically equivalent to calcium borogluconate .......................................... 26.0% w/v

Dextrose  H2O ......................................................................................................... 15.0% w/v

Magnesium Borogluconate ............................................................................................ 6.0% w/v

Total phosphorus in amounts chemically equivalent to elemental phosphorus ...................... 0.5% w/v

STORAGE AND HANDLING

Store between 15°C-30°C (59°F-86°F).

PRECAUTIONS

TAKE TIME OBSERVE LABEL DIRECTIONS

INFORMATION FOR OWNERS/CAREGIVERS

Manufactured by:

Nova-Tech, Inc.

Grand Island, NE 68801 USA

18-811

RMS 92-340

NDC# 65207-811-50

Net Contents:

500 mL (16.91 fl oz)

Assembled in USA

Lot No.

Exp. Date

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

NORCALPHOS 
norcalphos injection, solution

Product Information
Product Type	PRESCRIPTION ANIMAL DRUG	Item Code (Source)	NDC: 65207-811
Route of Administration	INTRAVENOUS, SUBCUTANEOUS

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Calcium Borogluconate (UNII: 6915G2PQI0) (CALCIUM CATION - UNII:2M83C4R6ZB)	CALCIUM CATION	26 g  in 100 mL
DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK)	DEXTROSE MONOHYDRATE	15 g  in 100 mL
MAGNESIUM GLUCONATE (UNII: T42NAD2KHC) (MAGNESIUM CATION - UNII:T6V3LHY838)	MAGNESIUM GLUCONATE	6 g  in 100 mL
Phosphorus (UNII: 27YLU75U4W) (PHOSPHORUS - UNII:27YLU75U4W)	Phosphorus	0.5 g  in 100 mL

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 65207-811-50	500 mL in 1 BOTTLE, PLASTIC

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		08/22/2019

Labeler - Nova-Tech, Inc. (196078976)

Registrant - Nova-Tech, Inc. (196078976)

Establishment
Name	Address	ID/FEI	Business Operations
Nova-Tech, Inc.		196078976	manufacture, api manufacture

Establishment
Name	Address	ID/FEI	Business Operations
Zhejiang Ruibang Laboratories		544807456	api manufacture

Establishment
Name	Address	ID/FEI	Business Operations
Jost Chemical Co.		147882294	api manufacture